Dr. Reddy’s Laboratories has launched Albendazole Tablets, USP, a generic version of GlaxoSmithKline’s Albenza Tablets, 200 mg, which are used for the treatment of a range of parasitic worm infestations.

Approved by the US Food and Drug Administration (FDA), Albenza brand and generic had sales of around $27 million MAT for the most recent twelve months ending in November 2020 as per IQVIA Health.

Dr. Reddy’s Laboratories said that its Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two.

  Albenza Tablets, Dr. Reddy’s Laboratories, GlaxoSmithKline, USA